Krupa Patel
Foot & Ankle Surgery · Morris Plains, NJNPI 1013240357
Payments from drug & device makers
Across 453 payments — averaging $620.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$277K
- Novus Surgical Solutions LLC$1K
- Averitas Pharma Inc.$645
- Organogenesis Inc.$257
- Kerecis Limited$225
- GRT US Holding, Inc.$159
- plus $1K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 326 | $277,289 |
| Novus Surgical Solutions LLC | 2 | $1,212 |
| Averitas Pharma Inc. | 51 | $645 |
| Organogenesis Inc. | 3 | $257 |
| Kerecis Limited | 2 | $225 |
| GRT US Holding, Inc. | 10 | $159 |
| Integra Lifesciences Corporation | 2 | $154 |
| Kowa Pharmaceuticals America, Inc. | 5 | $147 |
| Smith+Nephew | 8 | $117 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $110 |
| Lifenet Health | 1 | $97 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $90 |
| Nevro Corp. | 4 | $82 |
| Tactile Systems Technology Inc | 3 | $73 |
| Convatec Inc. | 3 | $62 |
| Zimmer Biomet | 2 | $42 |
| Osiris Therapeutics Inc. | 2 | $39 |
| Johnson & Johnson | 1 | $39 |
| Hydrocision, Inc. | 1 | $37 |
| AbbVie | 2 | $36 |
| Abbott | 2 | $33 |
| Arthrosurface Incorporated | 2 | $33 |
| Treace Medical Concepts, Inc. | 2 | $32 |
| Reapplix Inc. | 1 | $32 |
| Misonix Inc | 1 | $22 |
| Merck | 1 | $21 |
| Next Science LLC | 1 | $21 |
| Amgen | 1 | $19 |
| Solventum Corporation | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Paragon 28, Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $13 |
How this compares
$281,196 in reported general payments places this provider in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in Morris Plains
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
- Anup PatelEast Brunswick$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.